ArticleAdvances in therapy2025

Pharmacokinetic Comparability and Safety Between Original and Citrate-Free Mirikizumab Formulations for Subcutaneous Injections: Results from Three Clinical Trials.

Yuki Otani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.